Bill · H.R. 6789· House(119-HR-6789)
Federal Prisons Naloxone Access Act of 2025
- Introduced
- 12/17/2025
- Last activity
- 12/17/2025 — Referred to the House Committee on the Judiciary.
- Sponsored by
- Valerie Foushee
- Cosponsors
- - 4 - 0
- Introduced
- In Committee
What this bill would do
The Federal Prisons Naloxone Access Act of 2025 requires the Bureau of Prisons to make opioid antagonist kits available throughout all Federal correctional facilities. These kits must be stored in specific locations, including medical units, staff breakrooms, and various congregational areas. The Director is tasked with ensuring kits are maintained at room temperature and regularly checked for expiration. Additionally, both staff and incarcerated persons must receive annual training on recognizing and treating opioid overdoses. The bill also mandates specific documentation requirements for every administration of the medication. Finally, the Director must submit an annual report to Congress regarding compliance and overdose numbers.
Yes
Does this do more about addiction and overdose deaths?+8
The bill mandates the widespread availability of opioid antagonist kits and annual training to combat overdoses in federal prisons.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased availability of life-saving medication: The Director of the Bureau of Prisons must ensure an adequate number of opioid antagonist kits are kept in many areas, such as living quarters, dining halls, and work locations, so they are available where people congregate (Section 2(a)(1)).
-
Improved emergency response capabilities: Incarcerated persons are permitted to access these kits to administer to those who are overdosing (Section 2(a)(3)).
-
Education and preparedness: Personnel and incarcerated persons will receive annual training from medical staff on how to recognize the signs and symptoms of an opioid overdose and how to administer the kits (Section 2(b)).
-
Legal protection for those helping others: Incarcerated persons cannot be held liable for administering an opioid antagonist kit if they act in good faith (Section 2(d)).
Potential Negative Impacts for People
- No negative impacts were explicitly identified in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Opioid Crisis Response+8
- 1/12/2026
- 1 Cosponsor added.
- 1/8/2026
- 1 Cosponsor added.
- 12/17/2025
- Referred to the House Committee on the Judiciary.
- 2 Cosponsors added.
- Introduced in House
Daniel GoldmanDemocrat · New York
Henry JohnsonDemocrat · Georgia
Summer LeeDemocrat · Pennsylvania
Lucy McBathDemocrat · Georgia